February 27, 2024 · Form 4 insider transaction
Tarriff Scott bought 12,950 shares of Eagle Pharmaceuticals, Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Represents shares of Common Stock received upon vesting of performance stock units ("PSUs") that were granted on February 2, 2021.; Reflects the transfer of 88,181 shares of Common Stock pursuant to a Rule 16a-12 transaction.